US-Head Quartered, End-to-End Oncology Pharmacology Solutions CRO

Champions Oncology is a global preclinical and clinical research services provider that offers end-to-end solutions to biopharma organizations. With the largest and most annotated bank of clinically relevant patient-derived xenograft (PDX) and primary hematological malignancy models, Champions delivers innovative highest-quality data through proprietary in vivo and ex vivo platforms. Through its large portfolio of cutting-edge bioanalytical platforms, groundbreaking data platforms and analytics, and scientific excellence, Champions enables the advancement of preclinical oncology drug discovery and development programs and clinical trials worldwide.

Champions Oncology offers:

PDX models – Solid and Liquid Tumor (<1,200 – WES and RNASeq, patient treatment history and in vivo drug test data available)
Syngeneic models (MC38, CT26, 4T1, EMT6, LLC, B16F10, RENCA)
Humanized models (PBMC, CD34, NK)
Human Cell Line Xenografts
Hematological In vivo and Ex Vivo Modeling (AML, ALL, CLL, MCL, DLBCL, MM, CMML, MDS)
3D Tumor Model Studies, 3D Organoid Studies
Ex Vivo Co-Culture Studies
Clinical Specialty Testing (flow cytometry, western blot, IHC, qPCR, ELISA, Luminex, ImmunoAssays)
Clinical Flow Cytometry Services